Ligand validation:4JAN

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 4JAN designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4JAN_NAG_I_504	28%	70%	0.242	0.894	0.54	0.59	-	-	0	0	100%	0.9333
4JAN_NAG_I_501	23%	63%	0.247	0.868	0.55	0.82	-	1	0	0	100%	0.9333
4JAN_NAG_G_501	17%	64%	0.271	0.853	0.53	0.81	-	1	0	0	100%	0.9333
4JAN_NAG_G_502	12%	69%	0.336	0.863	0.49	0.69	-	-	0	0	100%	0.9333
4JAN_NAG_G_504	9%	62%	0.327	0.825	0.47	0.95	-	1	0	0	100%	0.9333
4JAN_NAG_G_505	9%	68%	0.331	0.826	0.52	0.69	-	-	1	0	100%	0.9333
4JAN_NAG_I_502	7%	67%	0.353	0.803	0.51	0.75	-	-	0	0	100%	0.9333
4JAN_NAG_G_503	5%	50%	0.37	0.774	0.49	1.42	-	3	4	0	100%	0.9333
4JAN_NAG_I_505	1%	67%	0.537	0.769	0.51	0.74	-	-	0	0	100%	0.9333
4JAN_NAG_I_503	1%	67%	0.606	0.704	0.49	0.75	-	-	1	0	100%	0.9333
4LST_NAG_G_501	69%	55%	0.132	0.946	0.47	1.25	-	2	0	0	100%	0.9333
1OC7_NAG_A_500	100%	60%	0.04	0.991	0.61	0.9	-	1	0	0	100%	0.9333
1OC6_NAG_A_500	100%	67%	0.041	0.988	0.46	0.8	-	1	0	0	100%	0.9333
1UWC_NAG_A_262	100%	54%	0.046	0.99	0.81	0.95	-	-	0	0	100%	0.9333
6ZE6_NAG_B_703	99%	52%	0.044	0.984	0.78	1.07	-	2	0	0	100%	0.8667
6ZE2_NAG_B_704	99%	56%	0.042	0.979	0.73	0.95	-	1	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.